Literature DB >> 330210

Some observations on the effect of Ro 7-1051 on Trypanosoma cruzi, particularly in cell culture.

S Yoneda, E Kimura, B R Castellani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330210     DOI: 10.1007/bf01922328

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  9 in total

1.  Nucleotide and polynucleotide synthesis in Trypanosoma cruzl. III. Effect of the aminonucleoside of stylomycin on the parasite in tissue culture.

Authors:  L H SILVA; S YONEDA; J F FERNANDES
Journal:  Exp Parasitol       Date:  1959-10       Impact factor: 2.011

2.  Chemotherapy of experimental Chagas' disease with thirty antibiotics.

Authors:  A PACKCHANIAN
Journal:  Am J Trop Med Hyg       Date:  1953-03       Impact factor: 2.345

3.  Activity of certain 6-methoxy-8-aminoquinolines against Trypanosoma cruzi.

Authors:  F C GOBLE
Journal:  Antibiot Chemother (Northfield)       Date:  1952-05

4.  Effect of primaquine on experimental Trypanosoma cruzi infection.

Authors:  T PIZZI
Journal:  Proc Soc Exp Biol Med       Date:  1951-11

5.  The chemotherapeutic action of phenanthridine compounds. II. Trypanosoma cruzi.

Authors:  L G GOODWIN; M D GOSS; J A LOCK; L P WALLS
Journal:  Br J Pharmacol Chemother       Date:  1950-06

6.  [Comparison of drug tolerance between nitrofurazone, levofuraltadone (NF-602) and Bay 2502].

Authors:  H de O Ferreira
Journal:  Bol Chil Parasitol       Date:  1969 Jan-Mar

7.  [Development of clinical symptoms and liver function in acute Chagas' disease treated with Bay 2502].

Authors:  H S Lugones; F Peralta; D C Feijóo; A E De Marteleur
Journal:  Bol Chil Parasitol       Date:  1969 Jan-Mar

8.  Studies with Bay 2502 on animals.

Authors:  M Bock; R Gönnert; A Haberkorn
Journal:  Bol Chil Parasitol       Date:  1969 Jan-Mar

9.  [Acute period of Chagas' disease and its treatment with Bay 2502].

Authors:  C L Bocca Tourres
Journal:  Bol Chil Parasitol       Date:  1969 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.